Description
Oxaliplatin-Tchaikapharma is an antineoplastic or anticancer drug and contains platinum. The active ingredient of Oxaliplatin-Tchaikapharma is oxaliplatin.
Indications
Oxaliplatin-Tchaikapharma is used to treat cancer of the large bowel (treatment of stage III colon cancer after complete resection of primary tumour, metastatic cancer of colon and rectum).
Subject to medical prescription.
Concentration and pharmaceutical form: 50 mg, 100 mg powder for solution for infusion
Description
Meropenem-Tchaikapharma belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria, which can cause serious infections.
Indications
Meropenem-Tchaikapharma is used to treat the following infections:
– Infection affecting the lungs (pneumonia);
– Lung and bronchial infections in patients suffering from cystic fibrosis;
– Complicated urinary tract infections;
– Complicated infections in the abdomen;
– Infections that you can catch during or after the delivery;
– Complicated skin and soft tissues infections;
– Acute bacterial infection of the brain (meningitis).
Subject to medical prescription.
Concentration and pharmaceutical form: 1 g powder for solution for injection/infusion
Description
Akinestat belongs to a group of medicines called anticholinergic agents, that counteract or block the action of acetylcholine. They have a central action and weak peripheral effects. As a result of the blockade of cholinergic receptors biperiden, an active substance of Akinestat relieves and eliminates the symptoms of parkinsonism.
Indications
Parkinson’s syndrome, especially with muscle rigidity and tremor. Extrapyramidal symptoms, such as acute dystonia, akathisia or Parkinson’s syndrome, provoked by neuroleptics or other drugs with a similar effect.
Subject to medical prescription.
Concentration and pharmaceutical form: 2 mg tablets
Description
Doxazosin-Tchaikapharma contains doxazosin – an α-blocker used to treat high blood pressure, and benign prostatic hyperplasia.
Indications
Hypertension
Doxazosin is indicated for the treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. In patients inadequately controlled on single antihypertensive therapy, doxazosin may be used in combination with a thiazide diuretic, beta-adrenoceptor blocking agent, calcium antagonist or an angiotensin-converting enzyme inhibitor.
Benign prostatic hyperplasia (BPH)
Doxazosin is indicated for the treatment of symptoms associated with benign prostatic hyperplasia (BPH) and by urinary outflow obstruction, related to BPH. Doxazosin may be used in BPH patients who are either hypertensive or normotensive. While in normotensive patients the changes in blood pressure were clinically insignificant, in patients with hypertension and BPH both conditions were effectively treated with doxazosin monotherapy.
Subject to medical prescription.
Concentrations and pharmaceutical form: 2 mg, 4 mg tablets
